Galena Pharma

Galena Pharma is a leading Finnish company specializing in the development, production, and support services of pharmaceuticals, medical devices, dietary supplements, and cosmetic products. Galena has comprehensive manufacturing capabilities across various product formats, such as tablets, capsules, gels, sprays and wound cleansers. In support services, Galena assists its clients in navigating sales licensing, registration affairs, as well as post-market surveillance.

Galena offers its integrated service concept primarily to Finnish and international pharmaceutical, pharma marketing and distribution companies focusing on the pharmacy channel. Over time and through investments in research and development, Galena has further advanced its specialization in managing the entire lifespan of medical devices. The firm emerged as a pioneer in Europe by securing the coveted MDR certification in 2022, among other esteemed accolades, all of which bear testament to its superior manufacturing capabilities and quality practices in the pharmaceutical sector.

In 2021, Intera Partners joined Galena’s journey as a new partner and shareholder, supporting the company’s growth and internationalization targets. The shared vision is to develop the company through sustainable practices into a global partner excelling in product development and manufacturing, underpinned by a trusted brand image and a pioneering reputation, especially within the field of medical devices.

Established in 1996, Galena Pharma’s operational hub is located in Kuopio. With a workforce of approximately 50 personnel, the firm primarily targets the EU, MENA, and Asian markets.